Book of the Dead

Ancient Egypt’s most precious relics are unearthed at Springbok Casino

Retrieved on:

Monday, August 22, 2022

Casino, Gaming, Entertainment, Online, Scarab, Free spin, Eye, AIL Desert Raider, Open-source video game, Wild, Horus, Desert, Death, Book of the Dead, Silk, Casino, Online gambling, Download, Ancient Egypt

In the latest addition to the Springbok Casino game lobby , Desert Raider looks to lead players through the temples of Ancient Egypt in search of the primeval civilisations precious, hidden relics.

Key Points:

In the latest addition to the Springbok Casino game lobby , Desert Raider looks to lead players through the temples of Ancient Egypt in search of the primeval civilisations precious, hidden relics.
Expected to go live with Springbok Casino on September 14th, 2022, Desert Raider will be available via Download, Instant Play and Mobile casino.
Daniel Van Wyke, Springbok Casino Manager, said: Desert Raider is going to take our players on an amazing journey littered with chances to win.
Desert Raider is the latest in a run of excellent additions to our game lobby, which we hope all our Springbok Casino fans will really enjoy.

MaaT Pharma to Provide Data Update for Lead Microbiome Biotherapeutic in Oral Presentation at 62nd American Society of Hematology (ASH) Annual Meeting

Retrieved on:

Thursday, November 26, 2020

Biotechnology, Health, Pharmaceutical, Clinical trials, Oncology, Book of the Dead, Maat

MaaT Pharma announced today that updated results from its compassionate use program for lead microbiome therapeutic MaaT013 will be reported in an oral presentation at the virtual 62nd American Society of Hematology (ASH) Annual Meeting held from December 5 -8, 2020.

Key Points:

MaaT Pharma announced today that updated results from its compassionate use program for lead microbiome therapeutic MaaT013 will be reported in an oral presentation at the virtual 62nd American Society of Hematology (ASH) Annual Meeting held from December 5 -8, 2020.
The results include data from 29 patients with gastrointestinal, acute Graft-versus-Host-Disease (aGvHD) who were resistant to multiple lines of treatments and were treated with the full-ecosystem microbiome restoration biotherapeutic.
MaaT Pharma provided the product to hospitals under an expanded access treatment program in France called Autorisation Temporaire dUtilisation Nominative (ATUn).
MaaT Pharma benefits from the commitment of world-leading scientists and established relationships with regulators to spearhead microbiome treatment integration into clinical practice.

MaaT Pharma Announces the Presentation of Positive Data with Its Lead Microbiome Biotherapeutic in Intestinal-Predominant Acute Graft-versus-Host-Disease at the ASH 2019 Annual Meeting

Retrieved on:

Saturday, December 7, 2019

MaaT Pharma announced today that leading hemato-oncological experts presented clinical data on the compassionate use of MaaT Pharmas lead full-ecosystem microbiome restoration biotherapeutic, MaaT013.

Key Points:

MaaT Pharma announced today that leading hemato-oncological experts presented clinical data on the compassionate use of MaaT Pharmas lead full-ecosystem microbiome restoration biotherapeutic, MaaT013.
The results were presented in a poster presentation on December7, 2019 during the 61st American Society of Hematology (ASH) Annual Meeting and Exposition held in Orlando, Florida.
MaaT013 is the first full-ecosystem, off-the-shelf, reproducible, enema formulation manufactured using MaaT Pharmas integrated Microbiome Restoration Biotherapeutic (MMRB) platform.
MaaT Pharma benefits from the commitment of world-leading scientists and established relationships with regulators to spearhead microbiome treatment integration into clinical practice.